azathioprine has been researched along with sirolimus in 145 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (9.66) | 18.2507 |
| 2000's | 90 (62.07) | 29.6817 |
| 2010's | 39 (26.90) | 24.3611 |
| 2020's | 2 (1.38) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kahan, BD | 4 |
| Engelbrecht, ME; Myburgh, JA; Oosthuizen, MM | 1 |
| Asselin, I; Guérette, B; Kinoshita, I; Lille, S; Roy, R; Tremblay, JP; Vilquin, JT | 1 |
| Almond, PS; Chen, S; Matas, A; Melin, M; Moss, A; Nakhleh, R; Salazar, A; Shirabe, K | 1 |
| Brattström, C; Claesson, K; Groth, CG; Herlenius, G; Säwe, J; Tydén, G | 1 |
| Sayegh, MH; Vella, JP | 1 |
| Aspeslet, LJ; Gallant, HL; Yatscoff, RW | 1 |
| Akizuki, E; Ichiguchi, O; Liang, J; Matsuda, T; Matsumura, F; Mori, K; Ogawa, M; Ohshiro, H; Okabe, K; Yamada, S; Yamaguchi, Y | 1 |
| Alho, H; Harjula, AL; Ikonen, T; Maasilta, P; Salminen, US; Taskinen, E | 1 |
| Aspeslet, LJ; Yatscoff, RW | 1 |
| Böttiger, Y; Brattström, C; Groth, CG; Säwe, J; Tydén, G; Wilczek, HE | 1 |
| Deol, HS; Tuch, BE; Wright, DC | 1 |
| Grinyó, JM | 1 |
| Alho, HS; Harjula, AL; Ikonen, TS; Maasilta, PK; Salminen, US; Taskinen, EI | 1 |
| Belitsky, P; Kiberd, B; Lawen, J; MacDonald, A; Mahalati, K; McAlister, V; West, K | 1 |
| Gleadle, JM; Mason, PD | 1 |
| Cristol, JP; Descomps, B; Dupuy, AM; Garrigue, V; Mourad, G; Tur, MD; Vela, C | 1 |
| Kahan, BD; Mahalati, K | 1 |
| Harjula, AL; Lautenschlager, IT; Maasilta, PK; Salminen, US; Taskinen, EI | 1 |
| Ettenger, RB; Grimm, EM | 1 |
| Coosemans, W; Evenepoel, P; Kuypers, DR; Maes, BD; Pirenne, J; Vanrenterghem, YF | 1 |
| Bäckman, L; Burke, JT; Kreis, H; Morales, JM; Taylor, R; Wilczek, H | 1 |
| Kushwaha, SS; Mayer, DF | 1 |
| Bäckman, L; Brattström, C; Calne, R; Campistol, JM; Charpentier, B; Claesson, K; Durand, D; Groth, CG; Kreis, H; Lang, P; Morales, JM; Touraine, JL; Wramner, L | 1 |
| Hricik, DE | 1 |
| Casarini, D; Felipe, CR; Franco, M; Garcia, R; Hanzawa, NM; Hosaka, BH; Lima, VC; Machado, PG; Medina-Pestana, JO; Motegi, S; Park, SI; Tedesco Silva, H | 1 |
| Avery, RK | 1 |
| Abeywickrama, KH; Bernhardt, P; Dorent, R; Eisen, HJ; Hummel, M; Kobashigawa, J; Lind, JM; Mancini, D; Starling, RC; Sørensen, K; Tuzcu, EM; Valantine-von Kaeppler, HA | 1 |
| Dorent, R; Eisen, H; Hsu, CH; Kovarik, JM; Mancini, D; Rordorf, C; Rouilly, M; Vigano, M | 1 |
| Braun, WE | 1 |
| Banas, B; Böger, C; Krämer, B | 1 |
| Derweesh, I; Flechner, SM; Goldfarb, D; Krishnamurthi, V; Mastroianni, B; Modlin, CS; Novick, A; Savas, K; Zhou, L | 1 |
| Pleyer, U | 1 |
| Mueller, XM | 1 |
| Azzola, A; Black, J; Chhajed, P; Glanville, A; Havryk, A; Hostettler, K; Johnson, P; Roth, M; Tamm, M | 1 |
| Doggrell, SA | 1 |
| Schulak, JA | 1 |
| Eisen, H; Ross, H | 1 |
| Shapiro, R | 1 |
| Alfieri, F; Felipe, CR; Franco, M; Garcia, R; Hanzawa, NM; Machado, PG; Medina-Pestana, JO; Park, SI; Silva, HT | 1 |
| Gentil, MA; González Roncero, FM; López, M; Martínez, M; Mateos, J; Pereira, P; Rodríguez Algarra, G; Toro, J; Valdivia, MA | 1 |
| Encke, J; Sauer, P; Stremmel, W; Uhl, W | 1 |
| Esmore, D; Faddy, S; Galbraith, A; Keogh, A; Macdonald, P; Muller, D; O'Driscoll, G; Richardson, M; Ruygrok, P; Spratt, P | 1 |
| Lo, A | 1 |
| Dorschner, L; Gallino, A; Ruschitzka, F; Seebach, JD; Speich, R | 1 |
| Alfieri, F; Casarini, D; Felipe, CR; Franco, M; Garcia, R; Machado, PG; Medina-Pestana, JO; Moreira, S; Park, SI; Tedesco-Silva, H | 1 |
| Kari, JA; Trompeter, RS | 1 |
| McDonald, RA; Nemeth, TL; Smith, JM | 1 |
| Alho, HS; Maasilta, PK; Päiväniemi, OE; Salminen, US; Wolff, CH | 1 |
| Hare, JM; Hauptman, P; Kovarik, JM; Mayer, HW; McCurry, KR; Schmidli, H; Starling, RC | 1 |
| Neuberger, J; Perry, I | 1 |
| Kobashigawa, J; Lindenfeld, J; Lowes, BD; Mestroni, L; Miller, GG; Page, RL; Shakar, SF; Wolfel, EE; Zolty, R | 1 |
| Dirks, NL; Huth, B; Meibohm, B; Yates, CR | 1 |
| Cantu, E; Cretin, N; Kaló, Z; Kauf, TL; Radeva, JI; Reed, SD; Schulman, KA | 1 |
| Baczkowska, T; Durlik, M | 1 |
| Valantine, H; Zuckermann, A | 1 |
| Valantine, H | 1 |
| Dugan, C; Emre, S; Gondolesi, G; Kerkar, N; Morotti, RA; Rumbo, C; Shneider, BL | 1 |
| Akiyama, Y; Aramaki, O; Ikeda, Y; Inoue, F; Kitajima, M; Matsumoto, K; Niimi, M; Shibutani, S; Shimazu, M; Shirasugi, N | 1 |
| Bailey, M; Kotsimbos, TC; Law, L; Levvey, BJ; Orsida, B; Snell, GI; Whitford, HM; Williams, TJ; Zheng, L | 1 |
| Kovarik, JM; Starling, RC | 1 |
| González-Posada, JM; Hernández, D | 1 |
| Ciancio, G; Gonwa, TA; Miller, J | 1 |
| Buell, JF; Gross, TG; Woodle, ES | 1 |
| Casarini, DE; Felipe, CR; Garcia, R; Machado, PG; Medina-Pestana, JO; Moreira, SR; Park, SI; Spinelli, GA; Tedesco-Silva, H | 1 |
| Aris, R; Glanville, AR; Hmissi, A; Loyd, JE; McGiffin, DC; Pirron, U; Roman, A; Snell, GI; Sole, A; Valentine, VG; Vitulo, P | 1 |
| Aris, R; Chan, CK; Kovarik, JM; Pirron, U; Schmidli, H; Snell, GI; Valentine, V | 1 |
| Fischereder, M; Graeb, C; Jauch, KW; Kammerl, MC; Krämer, BK; Krüger, B; Zülke, C | 1 |
| Calabrese, S; Sparacino, V | 1 |
| Eisen, H | 1 |
| Cheng, Y; Cherikh, WS; Hanto, DW; Kauffman, HM; McBride, MA | 1 |
| Hoitsma, AJ; van den Akker, JM; Wetzels, JF | 1 |
| Chi, NH; Chou, NK; Hsu, RB; Ko, WJ; Tsao, CI; Wang, CH; Wang, SS; Wu, FL | 1 |
| Chalermsanyakorn, P; Changsirikulchai, S; Lothuvachai, T; Sumethkul, V | 1 |
| Barbari, AG; Masri, MA; Stephan, AG | 1 |
| Gustafsson, F; Ross, HJ | 1 |
| Beaumont, BW; Copeland, JW; Merrilees, MJ; Pilmore, HL | 1 |
| Benavente, D; Buckel, E; Contreras, L; Ferrario, M; Fierro, A; Herzog, C; Morales, J; Zehnder, C | 1 |
| Carreño, CA; Gadea, M | 1 |
| Abeywickrama, K; Benza, R; Boissonnat, P; Cretin, N; Eisen, HJ; Haverich, A; Hill, J; Laufer, G; Love, R; Parameshwar, J; Pulpón, LA; Renlund, D; Starling, RC; Tuzcu, M; Viganò, M | 1 |
| Bailey, M; Kotsimbos, TC; Levvey, BJ; Orsida, B; Snell, GI; Williams, TJ; Zheng, L | 1 |
| Járay, J; Kahan, BD; Langer, R; Máthé, Z; Remport, A; Tóth, A | 1 |
| Snell, GI; Westall, GP | 1 |
| Bae, JH; Clavell, AL; Edwards, BS; Frantz, RP; Khalpey, Z; Kremers, WK; Kushwaha, SS; Lerman, A; Raichlin, E; Rihal, C; Rodeheffer, RJ | 1 |
| Mudge, GH | 1 |
| Abbott, KC; Axelrod, D; Brennan, DC; Buchanan, PM; Burroughs, TE; Dzebisashvili, N; Lentine, KL; Salvalaggio, PR; Schnitzler, MA; Willoughby, LM | 1 |
| Almeida, JM; Ikeda, MY; Saber, LT | 1 |
| Annemans, L; Hetzer, R; Lemkuhl, H; Ricci, JF; Schulz, U; Tenderich, G; Yang, XL | 1 |
| Armstrong, VW; Brandhorst, G; Koerfer, R; Oellerich, M; Oezpeker, C; Tenderich, G; Zittermann, A | 1 |
| Campbell, S; Chadban, SJ; Chang, SH; McDonald, SP; Russ, GR | 1 |
| Adamkovic, AB; Blum, MD; Caulfield, ME; Demopoulos, LA; Hembekides, DD; Rothrock, LC; Schubert, CM; Singh, AB; Steele, GH | 1 |
| Anglicheau, D; Beaune, P; Legendre, C; Thervet, E | 1 |
| Alexeeva, O; Feagan, B; Haas, T; Korom, S; Lémann, M; Mayer, H; Mikhailova, T; Panés, J; Reinisch, W; Sanna, L; Schmidt, S; Schreiber, S; Sturniolo, GC | 1 |
| de Prada, JA; Exposito, V; Fernández-Friera, L; García-Camarero, T; González-Vílchez, F; Llano, M; Martín-Durán, R; Ruano, J | 1 |
| El-Agroudy, AE; El-Dahshan, KF; Gad, ZA; Ghoneim, MA; Ismail, AM; Sheashaa, HA; Shokeir, AA; Wafa, EW | 1 |
| Hu, XP; Ma, LL; Wang, W; Wang, Y; Yang, XY; Yin, H; Zhang, XD | 1 |
| Baran, D; Birnbaum, LM; Cantarovich, M; Chaudhury, P; Herrera-Gayol, A; Lipman, M; Paraskevas, S; Tchervenkov, J | 1 |
| Coelho, LG; Lasmar, EP; Lasmar, LF; Lasmar, MF; Lima, PV; Nogueira, AF | 1 |
| Abraham, M; Al-Muzairai, I; Al-Otaibi, T; Al-Waheeb, S; Balaha, MA; Halim, MA; Hamid, MH; Johny, KV; Nair, MP; Nampoory, MR; Said, T; Tawab, KA | 1 |
| Badiwala, M; Prodger, J; Ramzy, D; Raoa, V; Ross, H; Sheshgiri, R; Tepperman, E | 1 |
| Davaus Gasparetto, T; Marchiori, E; Menezes, P; Zanetti, G | 1 |
| Fischer, L; Nashan, B; Schaefer, H; Staufer, K; Sterneck, M | 1 |
| Balal, M; Binokay, F; Demir, E; Erken, U; Kurt, C; Paydas, S; Sertdemir, Y; Sikgenc, MM | 1 |
| Ahya, VN; Alex, CG; Arcasoy, SM; Bag, R; Baz, MA; Bhorade, S; Charbeneau, J; Deoliveira, NC; Durazo-Arvizu, R; Garrity, E; Husain, A; Krishnan, JA; Love, RB; Norwick, L; Seethamraju, H; Valentine, VG; Vigneswaran, WT | 1 |
| Ahya, VN; Alex, CG; Arcasoy, SM; Bag, R; Baz, MA; Bhorade, S; Charbeneau, J; DeOliveira, NC; Durazo-Arvizu, R; Garrity, E; Krishnan, JA; Love, RB; McShane, PJ; Norwick, L; Seethamraju, H; Valentine, VG; Vigneswaran, WT | 1 |
| Celik, S; Dengler, TJ; Doesch, AO; Ehlermann, P; Frankenstein, L; Katus, HA; Konstandin, M; Kristen, A; Müller, S; Sack, FU | 1 |
| Chen, H; Egan, JJ | 1 |
| Kobashigawa, JA; Patel, JK | 1 |
| Arora, S; Aukrust, P; Bendz, B; Bøtker, HE; Eiskjær, H; Ekmehag, B; Gude, E; Gullestad, L; Jansson, K; Mortensen, SA; Saunamaki, K; Sigurdadottir, V; Simonsen, S; Solbu, D; Ueland, T; Wennerblom, B | 1 |
| Arizon, JM; Barten, MJ; Dong, G; Eisen, HJ; Kobashigawa, J; Lehmkuhl, H; Pelligrini, C; Ross, H; Wang, SS; Zuckermann, A | 1 |
| Mishra, OP; Mittal, R; Prasad, R; Singh, UK | 1 |
| Ghoneim, MA; Ismail, AM; Kamal, AI; Mahmoud, KM; Refaie, AF; Sheashaa, HA | 1 |
| Lee, EK; Mao, PC; Tseng, PL | 1 |
| Cheng, CY; Shu, KH; Tsai, SF; Wu, MJ | 1 |
| Alonso, EM; Ekong, UD; Mathew, J; Melin-Aldana, H; Wang, D | 1 |
| Bootun, R | 1 |
| Gossmann, J; Graff, J; Harder, S; Reiche, C; Scheuermann, EH | 1 |
| Bara, C; Delgado, JF; Dengler, T; Dong, G; Junge, G; Kobashigawa, J; Lehmkuhl, HB; Potena, L; Ross, H; Wang, SS; Witte, S | 1 |
| Chan, AJ; Lake, JR | 1 |
| Wagner, JA | 1 |
| Carroll, RP; Harden, PN; Hester, J; Wood, KJ | 1 |
| Bröker, BM; Brunner-Weinzierl, MC; Dummer, A; Evert, M; Fitzner, B; Jaster, R; Kraatz, F; Lerch, MM; Mayerle, J; Nizze, H; Salem, T; Schwaiger, T; van den Brandt, C; Wartmann, T; Zaatreh, S | 1 |
| Agena, F; Azevedo, LS; David-Neto, E; Gamba, C; Gerhard, J; Miraglia, JL; Pierrotti, L; Precioso, AR; Shikanai Yasuda, MA; Tavares Timenetsky, MD | 1 |
| Aleksić, P; Drasković-Pavlović, B; Dujić, A; Hrvacević, R; Ignjatović, L; Jovanović, D; Karan, Z; Kovacević, Z; Maksić, D; Rabrenović, V; Tomić, A; Vavić, N | 1 |
| Czaja, AJ | 1 |
| Allen, L; Boyer, TD; Chatrath, H | 1 |
| Hesselink, DA; van Gelder, T; van Schaik, RH | 1 |
| Chan, TM | 1 |
| Montero, N; Pascual, J | 1 |
| Campistol, JM; Canha, C; Castells, A; Diekmann, F; Ferreira, R; Moya-Rull, D; Oppenheimer, F; Revuelta, I; Rovira, J | 1 |
| Karam, S; Wali, RK | 1 |
| Aleksiejuk, P; Banki, K; Bonilla, E; Francis, L; Landas, SK; Liu, Y; Marchena-Mendez, I; Oaks, Z; Patel, J; Perl, A; Yu, J | 1 |
| Anglicheau, D; Babinet, F; Caillard, S; Colosio, C; Deslée, G; Dury, S; Essig, M; Etienne, I; Launois, C; Lebargy, F; Merieau, E; Perotin-Collard, JM; Rieu, P; Rivalan, J; Subra, JF; Thervet, E; Toubas, O | 1 |
| Anderson, R; Bond, M; Coelho, H; Cooper, C; Crathorne, L; Dudley, J; Haasova, M; Huxley, N; Hyde, C; Jones-Hughes, T; Lowe, J; Marks, S; Mujica-Mota, R; Snowsill, T; Varley-Campbell, J | 1 |
| Davidson, BR; Guerrero-Misas, M; Gurusamy, KS; Rodríguez-Perálvarez, M; Thorburn, D; Tsochatzis, E | 1 |
| Almeida, RAMB; Calazans, CAC; Charpiot, IMMF; Costa, KMAH; Cristelli, MP; de Lima, PR; de Sandes-Freitas, TV; Deboni, LM; Ferreira, GF; Ferreira, TCA; Garcia, VD; Manfro, RC; Mazzali, M; Medina-Pestana, J; Modelli de Andrade, LG; Nakamura, MR; Oriá, RB; Pacheco-Silva, A; Requião-Moura, LR; Simão, DR; Tedesco-Silva, H; Viana, LA | 1 |
| Camacho, I; Dave, Y; Eckembrecher, DG; Eckembrecher, FJ; Nouri, K; Patel, S; Shah, H | 1 |
43 review(s) available for azathioprine and sirolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New immunosuppressive drugs--pharmacologic approaches to alter immunoregulation.
Topics: Animals; Antimetabolites; Azathioprine; Biphenyl Compounds; Cell Differentiation; Cyclosporine; Guanidines; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocytes; Lymphokines; Oligonucleotides, Antisense; Polyenes; Receptors, Cytokine; Ribonucleosides; Signal Transduction; Sirolimus; Tacrolimus | 1994 |
The monitoring of immunosuppressive drugs: a pharmacodynamic approach.
Topics: Azathioprine; Cyclosporine; Drug Monitoring; Humans; Immunosuppressive Agents; Methylprednisolone; Mycophenolic Acid; Sirolimus | 1998 |
Progress with cyclosporine-sparing regimens.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Sirolimus; Transplantation, Homologous | 1999 |
Pharmacological surrogates of allograft outcome.
Topics: Animals; Azathioprine; Cyclosporine; Drug Monitoring; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mycophenolic Acid; Organ Transplantation; Sirolimus; Steroids; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2000 |
Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients.
Topics: Adolescent; Age Factors; Azathioprine; Child; Child, Preschool; Clinical Trials as Topic; Cyclosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Everolimus; Graft Rejection; Graft Survival; Half-Life; Humans; Immunosuppressive Agents; Intestinal Absorption; Kidney Transplantation; Prednisone; Sirolimus; Treatment Outcome | 2001 |
Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases.
Topics: Autoimmune Diseases; Azathioprine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Rheumatic Diseases; Severity of Illness Index; Sirolimus; Tacrolimus; Transplants; Treatment Outcome | 2003 |
Renal transplantation: basic concepts and evolution of therapy.
Topics: Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Fingolimod Hydrochloride; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Propylene Glycols; Receptors, Interleukin-2; Sirolimus; Sphingosine; Tacrolimus | 2003 |
[Immunomodulation in penetrating keratoplasty. Current status and perspectives].
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Animals; Antiviral Agents; Azathioprine; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Keratitis, Herpetic; Keratoplasty, Penetrating; Methotrexate; Mice; Multicenter Studies as Topic; Mycophenolic Acid; Pilot Projects; Prospective Studies; Risk Factors; Sirolimus; Tacrolimus | 2003 |
Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants.
Topics: Adrenal Cortex Hormones; Antibodies; Azathioprine; Calcineurin Inhibitors; Graft Rejection; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mycophenolic Acid; Sirolimus; Transplantation Immunology | 2004 |
Steroid immunosuppression in kidney transplantation: a passing era.
Topics: Adrenal Cortex Hormones; Azathioprine; Blood Pressure; Cyclosporine; Diabetes Mellitus; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Kidney; Kidney Transplantation; Lipid Metabolism; Sirolimus; Substance Withdrawal Syndrome; Transplantation Immunology | 2004 |
Optimizing the immunosuppressive regimen in heart transplantation.
Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Dose-Response Relationship, Drug; Everolimus; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Sirolimus | 2004 |
Low toxicity immunosuppressive protocols in renal transplantation.
Topics: Azathioprine; Calcineurin Inhibitors; Cyclosporine; Dose-Response Relationship, Drug; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Prospective Studies; Random Allocation; Retrospective Studies; Sirolimus; Steroids; Tacrolimus; Time Factors; Treatment Outcome | 2004 |
Immunosuppression and modulation in liver transplantation.
Topics: Azathioprine; Calcineurin Inhibitors; Glucocorticoids; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Living Donors; Mycophenolic Acid; Sirolimus; Tacrolimus | 2004 |
Strategies to prevent chronic allograft nephropathy in kidney transplantation: focus on calcineurin inhibitors.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Mycophenolic Acid; Patient Selection; Postoperative Care; Safety; Sirolimus; Tacrolimus; Transplantation, Homologous | 2004 |
What is the calcineurin inhibitor of choice for pediatric renal transplantation?
Topics: Azathioprine; Calcineurin Inhibitors; Child; Clinical Trials as Topic; Cyclosporine; Growth and Development; Hematologic Neoplasms; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Care; Sirolimus; Tacrolimus | 2004 |
Immunosuppression: towards a logical approach in liver transplantation.
Topics: Adrenal Cortex Hormones; Algorithms; Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Cardiovascular Diseases; Graft Rejection; Humans; Immune Tolerance; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Sirolimus | 2005 |
Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
Topics: Administration, Oral; Adrenal Cortex Hormones; Antimetabolites; Azathioprine; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Everolimus; Graft Rejection; Growth Inhibitors; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Protein Kinase Inhibitors; Protein Kinases; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases; Transplantation, Homologous | 2004 |
Pharmacokinetics of immunosuppressants: a perspective on ethnic differences.
Topics: Azathioprine; Black People; Cyclosporine; Cytochrome P-450 Enzyme System; Everolimus; Graft Survival; Humans; Immunosuppressive Agents; Mycophenolic Acid; Organ Transplantation; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus; White People | 2004 |
[Immunossupresive drugs in renal transplantation].
Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Propylene Glycols; Risk Factors; Rituximab; Sirolimus; Sphingosine; Tacrolimus | 2004 |
From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation.
Topics: Azathioprine; Clinical Medicine; Clinical Trials as Topic; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Everolimus; Glucocorticoids; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Sirolimus; Transplantation, Homologous | 2005 |
[Evidences in immunosuppression in the maintenance of renal transplantation].
Topics: Adult; Azathioprine; Calcineurin Inhibitors; Clinical Trials as Topic; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Meta-Analysis as Topic; Multicenter Studies as Topic; Mycophenolic Acid; Risk Factors; Sirolimus | 2005 |
Review of major clinical trials with mycophenolate mofetil in renal transplantation.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Azathioprine; Child; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Multicenter Studies as Topic; Mycophenolic Acid; Receptors, Interleukin-2; Sirolimus; Tacrolimus | 2005 |
Malignancy after transplantation.
Topics: Azathioprine; Calcineurin Inhibitors; Carcinoma, Hepatocellular; Cyclosporine; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Mycophenolic Acid; Neoplasms; Sirolimus; Skin Neoplasms; Tacrolimus; Transplantation Immunology; Transplantation, Homologous | 2005 |
Post-transplant de novo malignancies in renal transplant recipients: the past and present.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Europe; Female; History, 20th Century; History, 21st Century; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Neoplasms; Ohio; Registries; Sirolimus; Tacrolimus; United States | 2006 |
Calcineurin inhibitor-free protocols: risks and benefits.
Topics: Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Mycophenolic Acid; Patient Selection; Risk Assessment; Sirolimus; Treatment Outcome | 2007 |
Proliferation signal inhibitors in cardiac transplantation.
Topics: Azathioprine; Calcineurin; Calcineurin Inhibitors; Cell Proliferation; Coronary Artery Disease; Dose-Response Relationship, Drug; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Signal Transduction; Sirolimus | 2007 |
Immunosuppression for lung transplantation: evidence to date.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Mycophenolic Acid; Sirolimus; Tacrolimus | 2007 |
Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Immunosuppressive Agents; Mycophenolic Acid; Organ Transplantation; Pharmacogenetics; Polymorphism, Genetic; Sirolimus; Tacrolimus | 2008 |
Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine.
Topics: Azathioprine; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Safety; Sirolimus; Treatment Outcome | 2008 |
Management of chronic allograft nephropathy: a systematic review.
Topics: Azathioprine; Biopsy; Calcineurin Inhibitors; Chronic Disease; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Mycophenolic Acid; Sirolimus; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2009 |
Surgical biology for the clinician: vascular effects of immunosuppression.
Topics: Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Cyclosporine; Delayed Graft Function; Endothelium, Vascular; Everolimus; Graft Rejection; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immune Tolerance; Immunosuppressive Agents; Sirolimus; Tacrolimus; Transplantation Immunology | 2010 |
Immunosuppressive therapy in children.
Topics: Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mercaptopurine; Methotrexate; Mycophenolic Acid; Nitriles; Sirolimus; Tacrolimus | 2011 |
Effects of immunosuppressive therapy on wound healing.
Topics: Animals; Azathioprine; Cyclosporine; Everolimus; Humans; Immunosuppressive Agents; Mycophenolic Acid; Rats; Sirolimus; Swine; Tacrolimus; Wound Healing; Wounds and Injuries | 2013 |
Immunosuppression in HCV-positive liver-transplant recipients.
Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Azathioprine; Basiliximab; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Daclizumab; Everolimus; Hepatitis C; Humans; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Mycophenolic Acid; Receptors, Interleukin-2; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2012 |
Current and prospective pharmacotherapy for autoimmune hepatitis.
Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Budesonide; Hepatitis, Autoimmune; Humans; Immunologic Factors; Immunosuppressive Agents; Liver; Mycophenolic Acid; Rituximab; Salvage Therapy; Sirolimus | 2014 |
Pharmacogenetics and immunosuppressive drugs in solid organ transplantation.
Topics: Azathioprine; Cyclosporine; Drug Monitoring; Everolimus; Evidence-Based Medicine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Organ Transplantation; Pharmacogenetics; Polymorphism, Genetic; Predictive Value of Tests; Sirolimus; Tacrolimus; Transplantation Immunology | 2014 |
Treatment of severe lupus nephritis: the new horizon.
Topics: Antimalarials; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Nephritis; Mycophenolic Acid; Ribonucleosides; Severity of Illness Index; Sirolimus; Tacrolimus | 2015 |
Immunosuppression and Post-transplant Hyperglycemia.
Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Everolimus; Graft Rejection; Humans; Hyperglycemia; Immunosuppressive Agents; Mycophenolic Acid; Postoperative Complications; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases; Transplantation | 2015 |
Current State of Immunosuppression: Past, Present, and Future.
Topics: Abatacept; Alemtuzumab; Animals; Antibodies, Monoclonal, Humanized; Azathioprine; Bone Marrow Transplantation; Calcineurin Inhibitors; Cyclosporine; Disease Models, Animal; Everolimus; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lung Transplantation; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus | 2015 |
Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
Topics: Abatacept; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Basiliximab; Child; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Everolimus; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Models, Economic; Mycophenolic Acid; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; Technology Assessment, Biomedical | 2016 |
Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.
Topics: Adult; Azathioprine; Bayes Theorem; Cyclosporine; Drug Therapy, Combination; Everolimus; Glucocorticoids; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Network Meta-Analysis; Odds Ratio; Retreatment; Sirolimus; Tacrolimus; Transplantation Immunology | 2017 |
A review of heart transplant immunosuppressants and nonmelanoma skin cancer.
Topics: Azathioprine; Everolimus; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Sirolimus; Skin Neoplasms; Tacrolimus | 2023 |
34 trial(s) available for azathioprine and sirolimus
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.
Topics: Adult; Aged; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Placebos; Polyenes; Prednisolone; Sirolimus | 1996 |
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Biopsy; Cyclosporine; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Prospective Studies; Sirolimus; Survival Rate; Treatment Outcome | 2000 |
Sirolimus steady-state trough concentrations are not affected by bolus methylprednisolone therapy in renal allograft recipients.
Topics: Adult; Azathioprine; Drug Combinations; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Sirolimus | 2002 |
Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Drug Therapy, Combination; France; Graft Rejection; Hospitals, University; Humans; Hypercholesterolemia; Hypertriglyceridemia; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Prednisolone; Prednisone; Sirolimus | 2003 |
Safety and efficacy of sirolimus in kidney transplant patients and in patients with coronary artery disease undergoing angioplasty.
Topics: Adult; Angioplasty, Balloon, Coronary; Azathioprine; Black People; Cadaver; Coronary Disease; Cyclosporine; Family; Female; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Living Donors; Male; Risk Assessment; Safety; Sirolimus; Tissue Donors; Transplantation, Homologous | 2003 |
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Topics: Adult; Aged; Azathioprine; Coronary Disease; Coronary Vessels; Cyclosporine; Cytomegalovirus Infections; Double-Blind Method; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Lipids; Male; Middle Aged; Reoperation; Sirolimus; Transplantation, Homologous; Tunica Intima; Ultrasonography, Interventional | 2003 |
Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure.
Topics: Adrenal Cortex Hormones; Area Under Curve; Azathioprine; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Safety; Sirolimus | 2003 |
An open-label randomized trial of the safety and efficacy of sirolimus vs. azathioprine in living related renal allograft recipients receiving cyclosporine and prednisone combination.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Prednisone; Prospective Studies; Safety; Sirolimus | 2004 |
Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.
Topics: Acute Disease; Adult; Azathioprine; Coronary Artery Disease; Creatinine; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Infections; Lipids; Sirolimus; Survival Analysis; Ultrasonography | 2004 |
Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine.
Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Sirolimus; Treatment Outcome | 2004 |
Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling.
Topics: Azathioprine; Drug Monitoring; Everolimus; Heart Transplantation; Humans; Immunosuppressive Agents; Metabolic Clearance Rate; Prospective Studies; Reproducibility of Results; Sirolimus | 2004 |
Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation.
Topics: Azathioprine; Clinical Trials as Topic; Cytomegalovirus Infections; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Prospective Studies; Sirolimus; Treatment Outcome | 2005 |
Everolimus alters the bronchoalveolar lavage and endobronchial biopsy immunologic profile post-human lung transplantation.
Topics: Anti-Inflammatory Agents; Azathioprine; Bronchoalveolar Lavage; Bronchoscopy; Cytokines; Double-Blind Method; Everolimus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Lymphocyte Count; Male; Middle Aged; Placebos; Postoperative Complications; Prospective Studies; Sirolimus | 2005 |
Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Everolimus; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lung; Lung Transplantation; Male; Middle Aged; Sirolimus; Syndrome | 2006 |
Everolimus in pulmonary transplantation: pharmacokinetics and exposure-response relationships.
Topics: Adult; Area Under Curve; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Drug Therapy, Combination; Everolimus; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Sirolimus; Treatment Outcome | 2006 |
Long-term cardiovascular risk in transplantation--insights from the use of everolimus in heart transplantation.
Topics: Azathioprine; Cardiovascular Diseases; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Everolimus; Glucocorticoids; Graft Rejection; Heart Transplantation; Hospital Costs; Humans; Immunocompromised Host; Immunosuppressive Agents; Pennsylvania; Postoperative Complications; Risk Factors; Sirolimus; Tunica Intima; Ultrasonography | 2006 |
Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients.
Topics: Aged; Azathioprine; Calcineurin Inhibitors; Carcinoma, Squamous Cell; Creatinine; Female; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Proteinuria; Sirolimus; Skin Neoplasms; Time Factors | 2006 |
Influence of everolimus on cyclosporine Neoral pharmacokinetics in Chinese de novo cardiac transplant recipients.
Topics: Adult; Azathioprine; China; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Sirolimus | 2006 |
Sirolimus attenuates the rate of progression of early chronic allograft nephropathy.
Topics: Adult; Azathioprine; Biopsy; Blood Pressure; Chronic Disease; Creatinine; Cyclosporine; Disease Progression; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Postoperative Complications; Sirolimus; Transplantation, Homologous; Treatment Outcome | 2006 |
Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: effect on renal function and proteinuria.
Topics: Aged; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Basiliximab; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Proteinuria; Recombinant Fusion Proteins; Sirolimus | 2007 |
Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cyclosporine; Double-Blind Method; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Function Tests; Middle Aged; Safety; Sirolimus; Transplantation, Homologous; Treatment Outcome | 2007 |
Interleukin-17 and airway inflammation: a longitudinal airway biopsy study after lung transplantation.
Topics: Azathioprine; Biopsy; Bronchoalveolar Lavage; CD4-Positive T-Lymphocytes; Double-Blind Method; Everolimus; Female; Gene Expression Regulation; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-17; Lung; Lung Transplantation; Male; Middle Aged; Pneumonia; Prospective Studies; Sirolimus | 2007 |
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Coronary Disease; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Transplantation, Homologous | 2007 |
Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantation.
Topics: Acute Disease; Adult; Azathioprine; Belgium; Cardiomyopathy, Dilated; Coronary Disease; Cost of Illness; Double-Blind Method; Everolimus; Female; Graft Rejection; Heart Transplantation; Hemodynamics; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Survival Analysis; Treatment Failure | 2007 |
A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.
Topics: Adolescent; Adult; Aged; Azathioprine; Crohn Disease; Double-Blind Method; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Placebos; Prospective Studies; Sirolimus; Statistics, Nonparametric; Steroids; Treatment Outcome | 2008 |
Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression.
Topics: Adult; Azathioprine; Costs and Cost Analysis; Female; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Mycophenolic Acid; Prospective Studies; Sirolimus | 2009 |
Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation.
Topics: Azathioprine; Bronchiolitis Obliterans; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Lung Transplantation; Male; Middle Aged; Sirolimus; Tacrolimus; Time Factors | 2011 |
Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation.
Topics: Azathioprine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Lung Transplantation; Male; Middle Aged; Prednisone; Prospective Studies; Risk Factors; Sirolimus; Tacrolimus; Venous Thromboembolism | 2011 |
Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial.
Topics: Aged; Azathioprine; C-Reactive Protein; Calcineurin Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Everolimus; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycophenolic Acid; Risk Factors; Scandinavian and Nordic Countries; Sirolimus; Ultrasonography, Interventional; Vascular Cell Adhesion Molecule-1; Vascular Diseases; von Willebrand Factor | 2011 |
Impact of de novo everolimus-based immunosuppression on incisional complications in heart transplantation.
Topics: Adult; Azathioprine; Cyclosporine; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Postoperative Complications; Risk Factors; Sirolimus | 2011 |
Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Azathioprine; Calcineurin Inhibitors; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Egypt; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Sirolimus; Steroids; Tacrolimus; Time Factors; Transplantation Conditioning; Treatment Outcome; Young Adult | 2011 |
Platelet activation markers after conversion from azathioprine to sirolimus based immunosuppression in renal transplant recipients.
Topics: Adult; Aged; Azathioprine; CD11b Antigen; Female; Flow Cytometry; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation; Sirolimus | 2012 |
Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation.
Topics: Adolescent; Adult; Aged; Azathioprine; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Postoperative Complications; Sirolimus; Statistics as Topic | 2013 |
Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.
Topics: Aged; Aged, 80 and over; Azathioprine; Calcineurin Inhibitors; Carcinoma, Squamous Cell; CD56 Antigen; Female; Forkhead Transcription Factors; Humans; Immune System; Immunosuppressive Agents; Kidney Transplantation; Killer Cells, Natural; Male; Middle Aged; Phenotype; Risk Factors; Single-Blind Method; Sirolimus; Skin Neoplasms; T-Lymphocytes; TOR Serine-Threonine Kinases; Transplantation | 2013 |
68 other study(ies) available for azathioprine and sirolimus
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Cyclosporin A, FK506, rapamycin: the use of a quantitative analytic tool to discriminate immunosuppressive drug interactions.
Topics: Animals; Azathioprine; Cyclosporine; Dexamethasone; DNA Replication; Dose-Response Relationship, Immunologic; Drug Interactions; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; Mercaptopurine; Polyenes; Rats; Rats, Inbred BUF; Rats, Inbred WF; Sirolimus; Tacrolimus | 1992 |
The effect of immunosuppressants on human leukocyte NADPH oxidase.
Topics: Antigen-Presenting Cells; Azathioprine; Cyclosporine; Guanidines; Humans; Immunosuppressive Agents; In Vitro Techniques; Monocytes; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Polyenes; Sirolimus; Tacrolimus | 1994 |
Myoblast allotransplantation in mice: degree of success varies depending on the efficacy of various immunosuppressive treatments.
Topics: Animals; Azathioprine; Cyclosporine; Graft Survival; Immunosuppression Therapy; Immunosuppressive Agents; Methylprednisolone; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Muscles; Muscular Dystrophy, Animal; Mycophenolic Acid; Polyenes; Sirolimus; Transplantation, Homologous | 1994 |
Rapamycin in a porcine renal transplant model.
Topics: Animals; Azathioprine; Biopsy; Creatinine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Immunosuppressive Agents; Kidney Transplantation; Polyenes; Prednisone; Sirolimus; Swine; Transplantation, Homologous | 1993 |
Maintenance pharmacological immunosuppressive strategies in renal transplantation.
Topics: Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Polyenes; Postoperative Care; Sirolimus; Steroids; Tacrolimus | 1997 |
Pharmacodynamic monitoring of immunosuppressive drugs.
Topics: Azathioprine; Calcineurin; Cyclosporine; Drug Monitoring; Graft vs Host Disease; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Methyltransferases; Mycophenolic Acid; Polyenes; Ribosomal Protein S6 Kinases; Sirolimus | 1998 |
Immunosuppressants decrease neutrophil chemoattractant and attenuate ischemia/reperfusion injury of the liver in rats.
Topics: Animals; Azathioprine; Cyclosporine; Drug Evaluation, Preclinical; Immunosuppressive Agents; Interleukin-16; Liver; Male; Neutrophils; Polyenes; Rats; Rats, Wistar; Reperfusion Injury; Sirolimus; Tacrolimus; Time Factors | 1998 |
Effects of rapamycin analogue SDZ RAD on obliterative lesions in a porcine heterotopic bronchial allograft model.
Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cartilage; Cyclosporine; Epithelium; Everolimus; Immunosuppressive Agents; Methylprednisolone; Mucous Membrane; Necrosis; Polyenes; Sirolimus; Swine; Transplantation, Heterotopic; Transplantation, Homologous | 1998 |
Hypertriglyceridemia in renal transplant recipients treated with sirolimus.
Topics: Adult; Aged; Azathioprine; Cholesterol; Drug Therapy, Combination; Humans; Hypertriglyceridemia; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Prednisolone; Sirolimus; Triglycerides | 1998 |
A comparison of the sensitivity of pig and human peripheral blood mononuclear cells to the antiproliferative effects of traditional and newer immunosuppressive agents.
Topics: Animals; Azathioprine; Cell Division; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; In Vitro Techniques; Islets of Langerhans Transplantation; Leukocytes, Mononuclear; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Methylprednisolone; Mycophenolic Acid; Phytohemagglutinins; Sirolimus; Species Specificity; Swine; Tacrolimus; Transplantation, Homologous | 1999 |
Prevention of small airway obliteration in a swine heterotopic lung allograft model.
Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Disease Models, Animal; Epithelium; Everolimus; Graft Rejection; Immunosuppressive Agents; Lung Transplantation; Postoperative Complications; Sirolimus; Swine; Transplantation, Heterotopic; Transplantation, Homologous | 2000 |
A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity more accurately than trough levels.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Period; Predictive Value of Tests; Prednisone; Sirolimus; Time Factors | 2000 |
Sirolimus vs azathioprine.
Topics: Azathioprine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Sirolimus | 2000 |
Apolipoprotein CIII is upregulated by anticalcineurins and rapamycin: implications in transplantation-induced dyslipidemia.
Topics: Adult; Apolipoprotein C-III; Apolipoproteins A; Apolipoproteins B; Apolipoproteins C; Azathioprine; Calcineurin Inhibitors; Cholesterol; Cyclosporine; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Postoperative Complications; Reference Values; Sirolimus; Tacrolimus; Triglycerides | 2000 |
Immune cells and immunosuppression in a porcine bronchial model of obliterative bronchiolitis.
Topics: Animals; Azathioprine; Bronchi; Bronchiolitis; Cyclosporine; Drug Therapy, Combination; Everolimus; Glucocorticoids; Graft Rejection; Immune System; Immunohistochemistry; Immunosuppression Therapy; Immunosuppressive Agents; Methylprednisolone; Sirolimus; Swine; Time Factors; Transplantation Immunology; Transplantation, Autologous; Transplantation, Homologous | 2001 |
Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Reoperation; Retrospective Studies; Risk Factors; Sirolimus; Steroids; Treatment Failure | 2002 |
Sirolimus: new preparation. No tangible advance in renal transplantation.
Topics: Azathioprine; Clinical Trials as Topic; Cyclosporine; Drug Approval; Drug Therapy, Combination; Europe; Graft Rejection; Humans; Hyperlipidemias; Hypokalemia; Immunosuppressive Agents; Kidney Transplantation; Sirolimus; Thrombocytopenia; United States; United States Food and Drug Administration | 2002 |
[To further improve transplantation results].
Topics: Azathioprine; Cyclosporine; Double-Blind Method; Everolimus; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Monitoring, Physiologic; Multicenter Studies as Topic; Organ Transplantation; Randomized Controlled Trials as Topic; Sirolimus; Treatment Outcome | 2002 |
Use of sirolimus to facilitate cyclosporine avoidance or steroid withdrawal in kidney transplant recipients.
Topics: Adrenal Cortex Hormones; Azathioprine; Cell Cycle; Creatinine; Cyclosporine; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Sirolimus; Time Factors | 2003 |
Cardiac-allograft vasculopathy.
Topics: Azathioprine; Coronary Disease; Cytomegalovirus Infections; Drug Therapy, Combination; Everolimus; Heart Transplantation; Humans; Immunosuppressive Agents; Sirolimus | 2003 |
Everolimus in cardiac-transplant recipients.
Topics: Azathioprine; Coronary Disease; Coronary Vessels; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Sirolimus | 2003 |
The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Sirolimus; Time Factors; Wound Healing | 2003 |
Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.
Topics: Adult; Aged; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cell Division; Cells, Cultured; Cyclosporine; Everolimus; Female; Fibroblasts; Humans; Immunosuppressive Agents; Infections; Lung Diseases; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Sirolimus; Tacrolimus | 2004 |
Is everolimus useful in preventing allograft rejection and vasculopathy after heart transplant?
Topics: Adrenal Cortex Hormones; Aged; Azathioprine; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Creatinine; Cyclosporins; Drug Therapy, Combination; Everolimus; Graft Rejection; Heart Transplantation; Humans; Middle Aged; Multicenter Studies as Topic; Peripheral Vascular Diseases; Sirolimus; Transplantation, Homologous | 2004 |
[Interstitial pneumonitis associated with sirolimus administration in a renal transplantation patient: a clinical case].
Topics: Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diagnosis, Differential; Diuretics; Doxazosin; Drug Therapy, Combination; Famotidine; Furosemide; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Diseases, Interstitial; Male; Muscular Diseases; Mycophenolic Acid; Pneumonia, Bacterial; Postoperative Complications; Prednisone; Sirolimus | 2004 |
Everolimus-induced drug fever after heart transplantation.
Topics: Aged; Azathioprine; Cardiomyopathy, Dilated; Drug Therapy, Combination; Everolimus; Fever; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Sirolimus | 2004 |
Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization.
Topics: Acute Disease; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Cyclosporine; Daclizumab; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Mycophenolic Acid; Sirolimus; Tacrolimus; Treatment Outcome | 2004 |
Cyclooxygenase-2 expression in experimental post-transplant obliterative bronchiolitis.
Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Chondrocytes; Cyclooxygenase 2; Cyclosporine; Disease Models, Animal; Epithelial Cells; Everolimus; Fibroblasts; Fibrosis; Immunohistochemistry; Immunosuppressive Agents; Isoenzymes; Macrophages; Methylprednisolone; Postoperative Period; Prostaglandin-Endoperoxide Synthases; Sirolimus; Swine | 2004 |
Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial.
Topics: Adult; Angioplasty, Balloon, Coronary; Azathioprine; Clinical Trials, Phase III as Topic; Coronary Disease; Coronary Vessels; Everolimus; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Transplantation, Homologous; Tunica Intima; Ultrasonography, Interventional | 2005 |
Rapamycin successfully treats post-transplant autoimmune hepatitis.
Topics: Autoantibodies; Azathioprine; Biopsy; Calcineurin Inhibitors; Child; Child, Preschool; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunosuppressive Agents; Infant; Infant, Newborn; Liver; Liver Diseases; Male; Mycophenolic Acid; Postoperative Complications; Prednisolone; Sirolimus; Time Factors; Transaminases; Treatment Outcome | 2005 |
Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen.
Topics: Adoptive Transfer; Animals; Azathioprine; CD4-Positive T-Lymphocytes; Cyclosporine; Dendritic Cells; Graft Survival; Immunosuppression Therapy; Immunosuppressive Agents; Interleukin-2; Isoantigens; Mice; Mycophenolic Acid; Sirolimus; Spleen; Tacrolimus; Time Factors; Tissue Donors; Trachea; Transplantation | 2005 |
Therapeutic drug monitoring for everolimus in heart transplant recipients: flawed model or a model for future use?
Topics: Azathioprine; Biopsy; Drug Monitoring; Drug Therapy, Combination; Everolimus; Glomerular Filtration Rate; Heart Transplantation; Humans; Immunosuppressive Agents; Metabolic Clearance Rate; Mycophenolic Acid; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography | 2005 |
Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation.
Topics: Adult; Azathioprine; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperlipidemias; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lipid Metabolism; Male; Prednisone; Severity of Illness Index; Sirolimus; Time Factors | 2006 |
Conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction.
Topics: Adult; Aged; Azathioprine; Blood Urea Nitrogen; Calcineurin Inhibitors; Creatinine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Transplantation, Homologous | 2006 |
Conversion to a proliferation signal inhibitor in a patient with coronary artery disease--a case report.
Topics: Angina Pectoris; Angioplasty; Azathioprine; Calcineurin Inhibitors; Cell Proliferation; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Postoperative Complications; Signal Transduction; Sirolimus; Treatment Outcome; Withholding Treatment | 2006 |
Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone.
Topics: Actins; Azathioprine; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cyclosporine; Epithelial Cells; Fibroblasts; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules, Proximal; Methylprednisolone; Mycophenolic Acid; Sirolimus; Transforming Growth Factor beta; Versicans | 2007 |
Case report of a kidney transplant recipient converted to everolimus due to malignancy: resolution of bronchiolitis obliterans organizing pneumonia without everolimus discontinuation.
Topics: Adrenal Cortex Hormones; Azathioprine; Cryptogenic Organizing Pneumonia; Cyclosporine; Everolimus; Female; Humans; Kidney Transplantation; Methylprednisolone; Middle Aged; Papillomavirus Infections; Polycystic Kidney Diseases; Postoperative Complications; Sirolimus; Vaginal Neoplasms | 2007 |
[Lymphocele and kidney transplantation].
Topics: Adult; Azathioprine; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphocele; Male; Middle Aged; Prednisone; Retrospective Studies; Risk Factors; Severity of Illness Index; Sirolimus | 2007 |
Sirolimus and cardiac transplantation: is it the "magic bullet"?
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Coronary Disease; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Transplantation, Homologous | 2007 |
Novel methods for tracking long-term maintenance immunosuppression regimens.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Data Collection; Enzyme Inhibitors; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Medical Records Systems, Computerized; Medicare; Mycophenolic Acid; Pharmacies; Prevalence; Sirolimus; Tissue and Organ Procurement; United States | 2008 |
Posttransplantation conversion to sirolimus-based immunosuppression: a single center experience.
Topics: Azathioprine; Drug Therapy, Combination; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Sirolimus; Tacrolimus; Treatment Outcome | 2007 |
Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor.
Topics: Area Under Curve; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Antagonism; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Sirolimus; Tacrolimus | 2008 |
Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
Topics: Administration, Oral; Adult; Antibodies; Antimetabolites; Australia; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Everolimus; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; New Zealand; Practice Patterns, Physicians'; Prednisolone; Protein Kinases; Registries; Sirolimus; Steroids; Tacrolimus; Time Factors; TOR Serine-Threonine Kinases | 2008 |
Pericardial effusion coincident with sirolimus therapy: a review of Wyeth's safety database.
Topics: Azathioprine; Cardiac Tamponade; Databases, Factual; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Pericardial Effusion; Sirolimus | 2008 |
Avoidance of calcineurin inhibitors with use of proliferation signal inhibitors in de novo heart transplantation with renal failure.
Topics: Administration, Oral; Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cell Division; Everolimus; Glomerular Filtration Rate; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney; Kidney Function Tests; Renal Insufficiency; Retrospective Studies; Sirolimus | 2008 |
Rapamycin instead of mycophenolate mofetil or azathioprine in treatment of post-renal transplantation urothelial carcinoma.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Urinary Bladder Neoplasms; Urothelium | 2009 |
Mucosa-associated lymphoid tissue gastric lymphoma regression in a renal transplant patient after conversion of the immunosuppression to sirolimus: a case report.
Topics: Adult; Azathioprine; Cyclosporine; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Lymphoma, B-Cell, Marginal Zone; Sirolimus; Stomach Neoplasms | 2009 |
Long-term follow-up of 100 high-risk renal transplant recipients converted from calcineurin inhibitors to sirolimus: a single center experience.
Topics: Adult; Azathioprine; Calcineurin Inhibitors; Creatinine; Diabetes Mellitus; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Intracranial Hypertension; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Sirolimus; Survival Analysis; Young Adult | 2009 |
Pulmonary toxicity associated with sirolimus following kidney transplantation: computed tomography findings.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; Diarrhea; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Metronidazole; Mycophenolic Acid; Pneumonia; Pneumonia, Bacterial; Pneumonia, Viral; Postoperative Complications; Sirolimus; Tacrolimus; Tomography, X-Ray Computed | 2010 |
Sirolimus addition to tacrolimus-based immunosuppression induces complete remission of post-transplant lymphoproliferative disorder in a liver transplant recipient.
Topics: Azathioprine; Female; Humans; Immunosuppression Therapy; Liver Transplantation; Lymphoma, Large B-Cell, Diffuse; Sirolimus; Steroids; Tacrolimus; Young Adult | 2010 |
Bone disease in renal transplantation and pleotropic effects of vitamin D therapy.
Topics: Azathioprine; Bone Density; Bone Diseases; Bone Diseases, Metabolic; Creatinine; Female; Humans; Kidney Transplantation; Lipids; Male; Methylprednisolone; Mycophenolic Acid; Osteonecrosis; Osteoporosis; Sirolimus; Vitamin D | 2010 |
Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal.
Topics: Adolescent; Adult; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Germany; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Mycophenolic Acid; Neoplasms; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Skin Neoplasms; Survival Rate; Time Factors; TOR Serine-Threonine Kinases; Transplantation, Homologous; Treatment Outcome; Young Adult | 2010 |
Tailoring immunosuppressive therapy for lung transplantation: moving beyond hand-me-down data.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Lung Transplantation; Randomized Controlled Trials as Topic; Sirolimus | 2011 |
Everolimus for cardiac allograft vasculopathy--every patient, at any time?
Topics: Azathioprine; Calcineurin Inhibitors; Cell Proliferation; Disease Progression; Drug Therapy, Combination; Everolimus; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Muscle, Smooth, Vascular; Mycophenolic Acid; Risk Factors; Sirolimus; Vascular Diseases | 2011 |
Trends in the use of immunosuppressive agents by outpatients after renal transplantation at a medical center in southern Taiwan.
Topics: Adult; Ambulatory Care; Azathioprine; Cyclosporine; Drug Costs; Drug Therapy, Combination; Drug Utilization; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Practice Patterns, Physicians'; Prednisolone; Sirolimus; Tacrolimus; Taiwan; Time Factors; Treatment Outcome | 2012 |
Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database.
Topics: Azathioprine; Cyclosporine; Databases as Topic; Drug Therapy, Combination; Drug Utilization; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; National Health Programs; Practice Patterns, Physicians'; Sirolimus; Tacrolimus; Taiwan; Time Factors; Treatment Outcome | 2012 |
Successful resolution of inflammation and increased regulatory T cells in sirolimus-treated post-transplant allograft hepatitis.
Topics: Azathioprine; CD4 Lymphocyte Count; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis; Humans; Immunosuppressive Agents; Infant; Liver; Liver Transplantation; Male; Postoperative Complications; Prednisone; Retrospective Studies; Single-Blind Method; Sirolimus; T-Lymphocytes, Regulatory; Tacrolimus; Treatment Outcome | 2012 |
Cancer after heart transplant: implications for practice.
Topics: Azathioprine; Carcinoma, Squamous Cell; Drug Therapy, Combination; Fatal Outcome; Glucocorticoids; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Pleural Neoplasms; Prednisone; Sirolimus; Skin Neoplasms; Tacrolimus | 2012 |
Autoimmune pancreatitis in MRL/Mp mice is a T cell-mediated disease responsive to cyclosporine A and rapamycin treatment.
Topics: Animals; Autoimmune Diseases; Azathioprine; Biomarkers; Cell Proliferation; CTLA-4 Antigen; Cyclosporine; Dexamethasone; Drug Administration Schedule; Female; Flow Cytometry; Immunosuppressive Agents; Lymphocyte Activation; Mice; Mice, Inbred Strains; Pancreas; Pancreatitis, Chronic; Poly I-C; Random Allocation; Sirolimus; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Treatment Outcome | 2014 |
Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors.
Topics: Antibodies, Viral; Azathioprine; Brazil; Cyclosporine; Female; Humans; Immunosuppressive Agents; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Kidney Transplantation; Male; Mycophenolic Acid; Pandemics; Prospective Studies; Risk Factors; Sex Factors; Sirolimus; Tacrolimus; White People | 2013 |
Conversion from calcineurin inhibitors to sirolimus of recipients with chronic kidney graft disease grade III for a period 2003-2011.
Topics: Adult; Azathioprine; Biomarkers; Calcineurin Inhibitors; Creatinine; Cytomegalovirus Infections; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Proteinuria; Renal Insufficiency, Chronic; Sirolimus; Time Factors; Treatment Outcome | 2013 |
Use of sirolimus in the treatment of refractory autoimmune hepatitis.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Bilirubin; Drug Resistance; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Mycophenolic Acid; Prednisone; Sirolimus; Young Adult | 2014 |
A case of esophageal adenocarcinoma on long-term rapamycin monotherapy.
Topics: Adenocarcinoma; Aged; Azathioprine; Biomarkers; Cyclosporine; Drug Substitution; Esophageal Neoplasms; Esophagectomy; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Neoplasm Proteins; Neoplasms, Second Primary; Phosphorylation; Postoperative Complications; Prednisone; Protein Processing, Post-Translational; Sarcoma, Kaposi; Signal Transduction; Sirolimus; Skin Neoplasms; TOR Serine-Threonine Kinases | 2015 |
Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.
Topics: Acetylcysteine; Adult; Alanine Transaminase; Antibodies, Antinuclear; Aspartate Aminotransferases; Azathioprine; Biomarkers; Cohort Studies; Complement System Proteins; Cyclosporine; Diabetes Mellitus; Female; Free Radical Scavengers; Humans; Immunosuppressive Agents; Liver Diseases; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prevalence; Retrospective Studies; Severity of Illness Index; Sex Distribution; Sirolimus | 2015 |
Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study.
Topics: Adult; Agammaglobulinemia; Aged; Aged, 80 and over; Azathioprine; Bronchiectasis; Chronic Disease; Cough; Cyclosporine; Everolimus; Female; Forced Expiratory Volume; Graft Rejection; Haemophilus Infections; Haemophilus influenzae; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Polycystic Kidney, Autosomal Dominant; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Rituximab; Sirolimus; Tacrolimus; Tomography, X-Ray Computed; Vital Capacity; Young Adult | 2015 |
The Mycophenolate-based Immunosuppressive Regimen Is Associated With Increased Mortality in Kidney Transplant Patients With COVID-19.
Topics: Azathioprine; Calcineurin Inhibitors; COVID-19; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Sirolimus; TOR Serine-Threonine Kinases | 2022 |